Filter
223
Filtered Results: 223
Text search:
India
Hypertension
Control
Initiative
Featured
Recommendations
22
New Publications
77
Language
Document type
No document type
124
Studies & Reports
47
Guidelines
27
Manuals
14
Training Material
7
Strategic & Response Plan
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
45
Latin America and the Carribbean
9
South–East Asia Region
8
Global
8
Ethiopia
7
Malawi
6
Nigeria
4
Kenya
4
Bangladesh
4
Myanmar / Burma
4
Nepal
3
Indonesia
3
South Africa
3
Africa
3
Uganda
2
Philippines
2
Pakistan
2
Zambia
2
Ukraine
2
Chile
2
Asia
2
Venezuela
2
Sierra Leone
1
Congo, Democratic Republic of
1
Ghana
1
Haiti
1
Tanzania
1
Mozambique
1
Argentina
1
Namibia
1
Peru
1
Brazil
1
Colombia
1
Bolivia
1
Mexico
1
Western and Central Europe
1
Russia
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
94
Clinical Guidelines
42
Public Health
21
Women & Child Health
12
Key Resources
6
Capacity Building
4
Annual Report MEDBOX
1
Toolboxes
NCDs
31
Mental Health
21
COVID-19
11
Global Health Education
9
HIV
8
TB
8
Caregiver
8
Planetary Health
7
Refugee
3
Pharmacy
3
Disability
2
Natural Hazards
2
Rapid Response
1
AMR
1
Health Financing Toolbox
1
Cerebrum. 2016 Jul-Aug; 2016: cer-10-16.
Published online 2016 Jul 1.
The World Health Organization (WHO) and United NationsHuman Settlements Programme (UN-HABITAT) joint globalreport, Hidden cities: unmasking and overcoming healthinequities in urban settings, exposes the extent to whichcertain city dwellers suffer disproportionately from a wide range of diseases and ...
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with...
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
A all for global Action. The Oral Health Atlas. Second edition
